ISSN 1662-4009 (online)

Previous issue | Volume 19 | ESPEYB19 | Next issue

Yearbook of Paediatric Endocrinology 2022

13. Global Health for the Paediatric Endocrinologist

Improving access to healthcare in pediatric endocrinology and diabetes

ey0019.13-1 | Improving access to healthcare in pediatric endocrinology and diabetes | ESPEYB19

13.1. World Health Organization model list of essential medicines for children - 8th list, 2021

World Health Organization, Geneva: 2021 (WHO/MHP/HPS/EML/2021.03) https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.03Brief Summary: A major change in the World Health Organization (WHO) 2021 list of essential medicines (EML) is the inclusion, in both the EML for adults and for children, of long-acting analogues of insulin as therapeutic alternatives to huma...

ey0019.13-2 | Improving access to healthcare in pediatric endocrinology and diabetes | ESPEYB19

13.2. A scoping review of the use of e-learning and e-consultation for healthcare workers in low- and middle-income countries and their potential complementarity

A Ionescu , PGM de Jong , SLS Drop , SC van Kampen

s.l.s.drop@erasmusmc.nl J Am Medical Informatics Assoc 2022; 29: 713–722. doi: 10.1093/jamia/ocab271Brief Summary: This scoping review found that data remain scarce on the potential synergy between e-learning (EL) training for healthcare workers (HCWs) and provider-to-HCW e-consultation (EC).Both e-learning (EL) training ...

ey0019.13-3 | Improving access to healthcare in pediatric endocrinology and diabetes | ESPEYB19

13.3. The role of non-governmental organizations in strengthening healthcare systems in low- and middle-income countries: lessons from Sante Diabete in Mali

B Besancon , A Sidibe , DS Sow , O Sy , J Ambard , JS Yudkin , D Beran

David.Beran@unige.ch Glob. Health Action 2022, VOL. 15, 2061239; doi: 10.1080/16549716.2022.2061239Brief Summary: In this perspective, the authors argue that non-governmental organisations (NGO), such as Santé Diabète, can play a role in the strengthening of health systems and can improve leadership and governance, service delivery and...

ey0019.13-4 | Improving access to healthcare in pediatric endocrinology and diabetes | ESPEYB19

13.4. A human rights-based approach to improve access to insulin and other aspects of diabetes care

F Brennan , P Williams , K Armstrong , E Klatman , N Donelan , GD Ogle , A Eussen , AJ Jenkins

fpbrennan@ozemail.com.au Diabetes Res Clin Pract 2022; 183: 109153. doi: 10.1016/j.diabres.2021.109153Brief Summary: In this perspective, the authors argue that a human rights-based approach to access to insulin empowers patients, families, and communities living with diabetes, and grounds actions by governments, clinicians, and non-governme...

ey0019.13-5 | Improving access to healthcare in pediatric endocrinology and diabetes | ESPEYB19

13.5. Access to insulin products in Pakistan: a national scale cross-sectional survey on prices, availability, and affordability

A Saeed , K Lambojon , H Saeed , Z Saleem , N Anwer , M Majid Aziz , W Ji , W Liu , C Chen , C Yang , Y Fang , Z-U-D Babar

yufang@mail.xjtu.edu.cn Front Pharmacol 2022 13:820621. doi: 10.3389/fphar.2022.820621Brief Summary: This national cross-sectional survey in Pakistan found poor availability of insulin in the public sector, even for brands manufactured by domestic companies.Access to insulin remains a major issue worldwide in low- and middl...

ey0019.13-6 | Improving access to healthcare in pediatric endocrinology and diabetes | ESPEYB19

13.6. Access to fludrocortisone and to hydrocortisone in children with congenital adrenal hyperplasia in the WHO Eastern Mediterranean region: it takes a village…

A Rowlands , A Deeb , A Ladjouze , RT Hamza , SA Musa , J Raza , F Jennane , A Abu-Libdeh , JP Chanoine , the GPED CAH Working Group

jchanoine@cw.bc.ca BMJ Global Health 2021;6:e007195. doi: 10.1136/bmjgh-2021-007195Brief Summary: This review found that access to oral fludrocortisone and hydrocortisone remains suboptimal in the WHO Eastern Mediterranean Region. Improvement requires a collaboration between health professionals, families of patients, health authorities, pharmaceutica...